Paul A Cohen
Overview
Explore the profile of Paul A Cohen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee Y, Whitely A, Burling M, Anderson L, Cohen P, Naidoo M, et al.
Int J Gynecol Cancer
. 2025 Feb;
35(2):100052.
PMID: 39971437
Objective: The Rare Ovarian Tumor Module forms part of the National Gynae-Oncology Registry (NGOR) which measures compliance with the optimal care pathways for gynecologic cancer in Australia. Our objectives were...
2.
Leitch M, Arshad A, Cohen P, Allanson E
Int J Gynecol Cancer
. 2025 Feb;
35(2):100037.
PMID: 39971429
Objective: To evaluate the impact of patient-initiated follow-up in surgically treated early-stage endometrial cancer on quality of life, survival, and health care costs in patients with low-risk early-stage endometrial cancer....
3.
Dicks E, Tyrer J, Ezquina S, Jones M, Baierl J, Peng P, et al.
Eur J Hum Genet
. 2025 Feb;
33(3):297-303.
PMID: 39939714
Rare, germline loss-of-function variants in a handful of DNA repair genes are associated with epithelial ovarian cancer. The aim of this study was to evaluate the role of rare, coding,...
4.
Sehouli J, Boer J, Brand A, Oza A, ODonnell J, Bennett K, et al.
Int J Gynecol Cancer
. 2024 Nov;
34(11):1677-1684.
PMID: 39496422
Findings from clinical trials have led to advancement of care for patients with gynecologic malignancies. However, restrictive inclusion of patients into trials has been widely criticized for inadequate representation of...
5.
Powell A, Hodgson A, Cohen P, Rabban J, Park K, McCluggage W, et al.
Int J Gynecol Pathol
. 2024 Aug;
43(5):436-446.
PMID: 39164939
Endocervical adenocarcinomas (EACs) are a group of malignant neoplasms associated with diverse pathogenesis, morphology, and clinical behavior. As a component of the International Society of Gynecological Pathologists International Endocervical Adenocarcinoma...
6.
Schofield C, Taaffe D, Newton R, Galvao D, Cohen P, Kim J, et al.
Cancer Rep (Hoboken)
. 2024 Aug;
7(8):e2155.
PMID: 39118235
Objectives: In ovarian and other cancers, low muscle mass and density are associated with poorer clinical outcomes. However, screening for cancer-related sarcopenia (typically defined as low muscle mass) is not...
7.
Lefkovits Y, Heriot N, Sporik A, Perera S, Friedlander M, Dixon C, et al.
BMC Health Serv Res
. 2024 Jul;
24(1):778.
PMID: 38978033
As medical treatment increasingly focuses on improving health-related quality of life, patient-reported outcome measures (PROMs) are an essential component of clinical research. The National Gynae-Oncology Registry (NGOR) is an Australian...
8.
Allanson E, Cohen P, Bristow R
Int J Gynecol Cancer
. 2024 Jun;
34(8):1311.
PMID: 38851241
No abstract available.
9.
Denisenko E, de Kock L, Tan A, Beasley A, Beilin M, Jones M, et al.
Nat Commun
. 2024 Apr;
15(1):2860.
PMID: 38570491
High-grade serous ovarian carcinoma (HGSOC) is genetically unstable and characterised by the presence of subclones with distinct genotypes. Intratumoural heterogeneity is linked to recurrence, chemotherapy resistance, and poor prognosis. Here,...
10.
Allanson E, Hari A, Ndaboine E, Cohen P, Bristow R
Int J Gynecol Cancer
. 2024 Mar;
34(3):451-458.
PMID: 38438180
Surgical decision making is complex and involves a combination of analytic, intuitive, and cognitive processes. Medicolegal, infrastructural, and financial factors may influence these processes depending on the context and setting,...